[Alteration of immunological parameters following CDDP-5-FU chemotherapy].
Tsukuda
M
M
Dept. of Head and Neck Surgery, Kanagawa Cancer Center.
Kubota
A
A
Yosida
T
T
Miyata
K
K
Sawaki
S
S
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000276:immunology*; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000145:classification; D008297:Male; D008875:Middle Aged
D002945:Cisplatin; D005472:Fluorouracil